China’s Impact Therapeutics seeks up to $117 million in Hong Kong IPO, term sheet shows

SINGAPORE, May 5 (Reuters) – Impact Therapeutics, a Chinese cancer-drug developer, aims to raise up to $117 million in a Hong Kong initial public offering, according to a term sheet seen by Reuters on …